LiveSpo Pharma

LiveSpo Pharma’s spore-based probiotic products, notably LiveSpo NAVAX (nasal spray), CLAUSY, and DIA 30, have published clinical data—including randomized controlled trials in international journals—showing rapid symptom relief and significant reductions in antibiotic use for respiratory and digestive indications. Specifically, NAVAX showed ~600x reduction of RSV concentration and ~400x reduction of influenza concentration versus saline; CLAUSY and DIA 30 reduced antibiotic use by 25% and shortened diarrhea recovery by 3–4 days in pediatric patients[7][5][8]. Programs are registered on ClinicalTrials.gov and endorsed by experts internationally.